SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 20th, 2021 • Pacific Biosciences of California, Inc. • Laboratory analytical instruments • New York
Contract Type FiledJuly 20th, 2021 Company Industry JurisdictionJuly 19, 2021 by and between Pacific Biosciences of California, Inc., a Delaware corporation (the “Company”), and each of the Investors identified on Exhibit A attached hereto (each an “Investor” and collectively the “Investors”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 20th, 2021 • Pacific Biosciences of California, Inc. • Laboratory analytical instruments • New York
Contract Type FiledJuly 20th, 2021 Company Industry JurisdictionThis REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of July 19, 2021 by and between Pacific Biosciences of California, Inc., a Delaware corporation (the “Company”), and each of the Investors named in Exhibit A to that certain Securities Purchase Agreement by and between the Company and each of the Investors, dated as of July 19, 2021 (the “Purchase Agreement”). Capitalized terms used herein have the respective meanings ascribed thereto in the Purchase Agreement unless otherwise defined herein.
AGREEMENT AND PLAN OF MERGER AND PLAN OF REORGANIZATION among PACIFIC BIOSCIENCES OF CALIFORNIA, INC. APOLLO ACQUISITION CORP. APOLLO ACQUISITION SUB, LLC. OMNIOME, INC. AND SHAREHOLDER REPRESENTATIVE SERVICES LLC, as Securityholder Representative...Merger Agreement • July 20th, 2021 • Pacific Biosciences of California, Inc. • Laboratory analytical instruments • Delaware
Contract Type FiledJuly 20th, 2021 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER AND PLAN OF REORGANIZATION (this “Agreement”) is made and entered into as of July 19, 2021 (the “Agreement Date”), among Pacific Biosciences of California, Inc., a Delaware corporation (“Acquiror”), Apollo Acquisition Corp, a Delaware corporation and a wholly owned subsidiary of Acquiror (“Merger Sub I”), Apollo Acquisition Sub, LLC, a Delaware limited liability company and direct wholly owned subsidiary of Acquiror (“Merger Sub II” and together with Merger Sub I, the “Merger Subs”), Omniome, Inc., a Delaware corporation (the “Company”), and Shareholder Representative Services LLC, a Colorado limited liability company, solely in its capacity as the agent for and on behalf of the Securityholders under this Agreement (the “Securityholder Representative”). All capitalized terms that are used but not defined in this Agreement shall have the respective meanings ascribed to such terms in Annex A.